Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Colorectal Neoplasms

  Free Subscription

Articles published in J Pathol

Retrieve available abstracts of 25 articles:
HTML format

Single Articles

    July 2021
  1. JIAO L, Eickhoff R, Egners A, Jumpertz S, et al
    Deletion of mTOR in liver epithelial cells enhances hepatic metastasis of colon cancer.
    J Pathol. 2021 Jul 26. doi: 10.1002/path.5768.
    PubMed     Abstract available

    April 2021
  2. LIU L, Li SW, Yuan W, Tang J, et al
    Downregulation of SUN2 promotes metastasis of colon cancer by activating BDNF/TrkB signalling by interacting with SIRT1.
    J Pathol. 2021 Apr 30. doi: 10.1002/path.5697.
    PubMed     Abstract available

    April 2020
  3. TOPI G, Satapathy SR, Dash P, Fred Mehrabi S, et al
    Tumour-suppressive effect of oestrogen receptor beta in colorectal cancer patients, colon cancer cells, and a zebrafish model.
    J Pathol. 2020 Apr 25. doi: 10.1002/path.5453.
    PubMed     Abstract available

  4. RAINEY L, Deevi RK, McClements J, Khawaja H, et al
    Fundamental control of grade-specific colorectal cancer morphology by Src regulation of ezrin-centrosome engagement.
    J Pathol. 2020 Apr 21. doi: 10.1002/path.5452.
    PubMed     Abstract available

  5. PALMIERI V, Lazaris A, Mayer TZ, Petrillo SK, et al
    Neutrophils expressing lysyl oxidase-like 4 protein are present in colorectal cancer liver metastases resistant to anti-angiogenic therapy.
    J Pathol. 2020 Apr 16. doi: 10.1002/path.5449.
    PubMed     Abstract available

  6. CERRETELLI G, Ager A, Arends MJ, Frayling IM, et al
    Molecular pathology of Lynch syndrome.
    J Pathol. 2020;250:518-531.
    PubMed     Abstract available

    March 2020
  7. CHAN AW, Pan Y, Tong JH, Lung RW, et al
    Receptor tyrosine kinase fusions act as a significant alternative driver of the serrated pathway in colorectal cancer development.
    J Pathol. 2020 Mar 11. doi: 10.1002/path.5418.
    PubMed     Abstract available

  8. KOMOR MA, Bosch LJ, Coupe VM, Rausch C, et al
    Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression.
    J Pathol. 2020;250:288-298.
    PubMed     Abstract available

  9. SOHIER P, Sanson R, Leduc M, Audebourg A, et al
    Proteome analysis of formalin-fixed paraffin-embedded colorectal adenomas reveals the heterogeneous nature of traditional serrated adenomas compared to other colorectal adenomas.
    J Pathol. 2020;250:251-261.
    PubMed     Abstract available

    February 2020
  10. LAVITRANO M, Ianzano L, Bonomo S, Cialdella A, et al
    BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers.
    J Pathol. 2020;250:134-147.
    PubMed     Abstract available

    December 2019
  11. HARUKI K, Kosumi K, Hamada T, Twombly TS, et al
    Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer.
    J Pathol. 2019 Dec 27. doi: 10.1002/path.5381.
    PubMed     Abstract available

    October 2019
  12. ZHANG Y, Liao Y, Chen C, Sun W, et al
    P38-regulated FOXC1 stability is required for colorectal cancer metastasis.
    J Pathol. 2019 Oct 24. doi: 10.1002/path.5362.
    PubMed     Abstract available

    March 2019
  13. ASHLEY N, Ouaret D, Bodmer WF
    Cellular polarity modulates drug resistance in primary colorectal cancers via orientation of the multidrug resistance protein ABCB1.
    J Pathol. 2019;247:293-304.
    PubMed     Abstract available

    January 2019
  14. CHEN LY, Zhi Z, Wang L, Zhao YY, et al
    NSD2 circular RNA promotes metastasis of colorectal cancer by targeting miR-199b-5p mediated DDR1 and JAG1 signalling.
    J Pathol. 2019 Jan 21. doi: 10.1002/path.5238.
    PubMed     Abstract available

  15. DOSIL MA, Navaridas R, Mirantes C, Tarragona J, et al
    Tumor suppressive function of E2F-1 on PTEN-induced serrated colorectal carcinogenesis.
    J Pathol. 2019;247:72-85.
    PubMed     Abstract available

    December 2018
  16. VALLE L, Vilar E, Tavtigian SV, Stoffel EM, et al
    Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine.
    J Pathol. 2018 Dec 25. doi: 10.1002/path.5229.
    PubMed     Abstract available

    August 2018
  17. MCCORRY AMB, Loughrey MB, Longley DB, Lawler M, et al
    Epithelial-to-mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition.
    J Pathol. 2018 Aug 13. doi: 10.1002/path.5155.
    PubMed     Abstract available

    June 2018
  18. LI X, Wang J, Zhang C, Lin C, et al
    Circular RNA circITGA7 inhibits colorectal cancer growth and metastasis by modulating the Ras pathway and upregulating transcription of its host gene ITGA7.
    J Pathol. 2018 Jun 26. doi: 10.1002/path.5125.
    PubMed     Abstract available

  19. CHOI TG, Nguyen MN, Kim J, Jo YH, et al
    Cyclophilin B induces chemoresistance by degrading wild type p53 via interaction with MDM2 in colorectal cancer.
    J Pathol. 2018 Jun 6. doi: 10.1002/path.5107.
    PubMed     Abstract available

    May 2018
  20. ETO T, Miyake K, Nosho K, Ohmuraya M, et al
    Impact of loss-of-function mutations at the RNF43 locus on colorectal cancer development and progression.
    J Pathol. 2018 May 13. doi: 10.1002/path.5098.
    PubMed     Abstract available

    March 2018
  21. DEEVI RK, Javadi A, McClements J, Vohhodina J, et al
    Protein kinase C zeta suppresses low- or high-grade colorectal cancer (CRC) phenotypes by interphase centrosome anchoring.
    J Pathol. 2018 Mar 9. doi: 10.1002/path.5035.
    PubMed     Abstract available

    February 2018
  22. ALDERDICE M, Richman SD, Gollins S, Stewart P, et al
    Prospective patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies.
    J Pathol. 2018 Feb 7. doi: 10.1002/path.5051.
    PubMed     Abstract available

    October 2017
  23. BINDER H, Hopp L, Schweiger MR, Hoffmann S, et al
    Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndrome.
    J Pathol. 2017;243:242-254.
    PubMed     Abstract available

    September 2017
  24. SHU XS, Zhao Y, Sun Y, Zhong L, et al
    PBRM1 restricts the basal activity of innate immune system through repressing RIG-I-like receptor signaling and is a potential prognostic biomarker for colon cancer.
    J Pathol. 2017 Sep 20. doi: 10.1002/path.4986.
    PubMed     Abstract available

    June 2017
  25. IRSHAD S, Bansal M, Guarnieri P, Davis H, et al
    Bone morphogenetic protein and Notch signalling crosstalk in poor-prognosis, mesenchymal-subtype colorectal cancer.
    J Pathol. 2017;242:178-192.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.